Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

Trial Profile

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2015

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Acronyms TROP
  • Most Recent Events

    • 15 Apr 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Actual initiation date (Oct 2009) added as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Planned end date changed from 1 Apr 2011 to 1 Oct 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top